Nanologica AB (publ) (FRA:4YD)

Market Cap	3.43M -75.2%
Revenue (ttm)	2.05M +158.4%
Net Income	-4.30M
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	500
Open	0.0450
Previous Close	0.0450
Day's Range	0.0450 - 0.0450
52-Week Range	0.0368 - 0.1740
Beta	n/a
RSI	37.19
Earnings Date	Feb 12, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2004
• Employees: 19
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YD

Financial Performance

In 2024, Nanologica AB's revenue was 14.54 million, an increase of 211.17% compared to the previous year's 4.67 million. Losses were -65.63 million, -12.68% less than in 2023.

Financial numbers in SEK